Physician

Michael Vincent Tallarico, M.D.

According to 2025 Medicare claims, Michael Tallarico, M.D. (NPI: 1467773036) practices internal medicine in the Lake County-Porter County-Jasper County, IN market, with the plurality of this provider's patient population coming from Lake, IN. This provider's primary affiliated billing organization is NORTHWEST CANCER CENTERS, PC (NPI: 1578527826; TIN: 30-0200047) and primary practice location at 46311-1596. Tallarico is affiliated with the Powers Health Partners ACO (ACO ID: A3632), participating under the MSSP model.

Tallarico's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 971 traditional Medicare patients, billed 242,952 HCPCS/CPT codes, and received $4,871,581 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,162 prescription claims across 309 beneficiaries totaling $4,250,851 in drug costs, led by Calquence (Acalabrutinib Maleate). 2023 DME data shows 49 claims. Open Payments data shows 167 records totaling $9,367. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $163,522 to $4,871,581. Similarly, Part D prescription costs have risen steadily, from $16,943 to $4,250,851. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	198	15,749	$163,522
2018	571	168,638	$1,026,466
2019	979	308,327	$2,083,727
2020	645	227,424	$2,467,374
2021	766	263,566	$3,478,412
2022	941	315,677	$4,633,475
2023	967	264,220	$5,193,858
2024	971	242,952	$4,871,581

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	33	70	$16,943
2016	31	89	$100,789
2017	41	116	$26,940
2018	125	658	$654,602
2019	241	1,663	$2,054,244
2020	253	1,797	$3,277,468
2021	260	1,927	$3,677,338
2022	283	1,938	$4,074,414
2023	290	1,883	$3,945,844
2024	309	2,162	$4,250,851

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	66	$1,934
2019	11	91	$2,713
2020	N/R	40	$1,324
2021	N/R	30	$2,939
2022	N/R	24	$607
2023	N/R	49	$15,210
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	577	1,712	$88
36415	Insertion of needle into vein for collection of blood sample	477	2,286	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	470	2,210	$8
82247	Bilirubin level, total	466	2,167	$5
82040	Albumin (protein) level	466	2,162	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	59	1,770	$870,429
Xtandi	Enzalutamide	24	720	$332,138
Jakafi	Ruxolitinib Phosphate	17	510	$284,897
Venclexta	Venetoclax	35	905	$245,653
Nubeqa	Darolutamide	16	480	$209,816

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	167	$9,367	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Vincent Tallarico, M.D.?

Tedicare shows public-source Medicare data for Michael Vincent Tallarico, M.D. (NPI 1467773036), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Vincent Tallarico, M.D. have ACO affiliation data?

Michael Vincent Tallarico, M.D. is shown with ACO affiliation data for Powers Health Partners ACO (MSSP, ACO ID A3632).

What billing organization is linked to Michael Vincent Tallarico, M.D.?

Michael Vincent Tallarico, M.D. is linked to NORTHWEST CANCER CENTERS, PC (billing NPI 1578527826) in the available physician profile data.

Does Michael Vincent Tallarico, M.D. have Open Payments data?

Michael Vincent Tallarico, M.D. has 167 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.